Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.
The FDA’s Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple myeloma patient population.
FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive to Bacillus Calmette-Guérin.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
By Annie W. Y. Chai, PhD; Pablo A. Sanchis, PhD; Hassan M. Abushukair, MD; and Mary A. Adewunmi, the members of the AACR Global Scholars Alumni Committee The American Association for Cancer Research (AACR) launched the Global Scholar-in-Training Award (GSITA) program in 2016 to
When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I am.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.
Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing.
Proposed shifts to OSHA may abolish the agency or limit its scope. Read here about potential changes & their impact on worker asbestos protections. The post If OSHA Is Dismantled, Will Worker Asbestos Protections Change? appeared first on Mesothelioma.com.
Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for patients with high-risk skin cancer.
SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to swallow pills access therapy.
